World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 2734419

Number of visits today: 1047

Number of downloads: 2005246

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Dube T, Kumar N, Bishnoi M, Panda JJ. Dual Blood-Brain Barrier-Glioma Targeting Peptide-Poly(levodopamine) Hybrid Nanoplatforms as Potential Near Infrared Phototheranostic Agents in Glioblastoma. Bioconjug Chem 2021;32:2014-31. [PMID: 34461019 DOI: 10.1021/acs.bioconjchem.1c00321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]

For:

Dube T, Kumar N, Bishnoi M, Panda JJ. Dual Blood-Brain Barrier-Glioma Targeting Peptide-Poly(levodopamine) Hybrid Nanoplatforms as Potential Near Infrared Phototheranostic Agents in Glioblastoma. Bioconjug Chem 2021;32:2014-31. [PMID: 34461019 DOI: 10.1021/acs.bioconjchem.1c00321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]

Number	Citing Articles
1	Dube T, Panda JJ. Anti-Glioma Activity Achieved by Dual Blood-Brain Barrier/Glioma Targeting Naive Chimeric Peptides-Based Co-Assembled Nanophototheranostics. Pharmaceutics 2023;15. [PMID: 36678895 DOI: 10.3390/pharmaceutics15010265] [Reference Citation Analysis]
2	An R, Liu L, Wei S, Huang Z, Qiu L, Lin J, Liu H, Ye D. Controlling Disassembly of Paramagnetic Prodrug and Photosensitizer Nanoassemblies for On-Demand Orthotopic Glioma Theranostics. ACS Nano 2022;16:20607-21. [PMID: 36508254 DOI: 10.1021/acsnano.2c07491] [Reference Citation Analysis]
3	Wang B, Hu X, Sun F, Yang Z, Huang W. Advanced strategic constructions of diketopyrrolopyrrole derivatives‐based organic semiconducting phototheranostics. Interdisciplinary Medicine 2022. [DOI: 10.1002/inmd.20220010] [Reference Citation Analysis]
4	Wang C, Cheng X, Peng H, Zhang Y. NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced Chemo/PDT/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinoma. Nanoscale Res Lett 2022;17:92. [PMID: 36125619 DOI: 10.1186/s11671-022-03729-w] [Reference Citation Analysis]
5	Neganova ME, Aleksandrova YR, Sukocheva OA, Klochkov SG. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin Cancer Biol 2022:S1044-579X(22)00155-9. [PMID: 35779712 DOI: 10.1016/j.semcancer.2022.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]